Balneotherapy, Osteoarthritis and Hypertension

Is there a clinically meaningful change in the blood pressure of osteoarthritis patients with comorbid hypertension during the course of Balneotherapy?

By Emrullah Hayta, Ilker Yayikçi, Zafer Özer, Özlem Sahin from the Department of Physical Medicine and Rehabilitation and Mehmet Birhan Yilmaz from the Department of Cardiology, Cumhuriyet University, Sivas Numune State Hospital, Sivas, Turkey | November 2015

The aim of the study is to investigate the effects of 3-week Balneotherapy on blood pressure of osteoarthritis patients with no hypertension, and controlled or uncontrolled hypertension.

Balneotherapy is a treatment modality that uses the physical and chemical effects of water, including thermomineral, acratothermal, and acratopegal waters. It has many effects on cardiovascular system.

Two hundred and seventy osteoarthritis patients were divided into three groups:

  1. No hypertension
  2. Controlled hypertension
  3. Uncontrolled hypertension

All groups received Balneotherapy in the Cumhuriyet university hospital facilities at the same time every day (10:00-11:30 AM) for 10 min per day, 5 days per week, for a total of 15 days in a 3-week period. Systolic and diastolic blood pressures and pulse rates were measured before and after Balneotherapy on daily basis.



The pulse rates of study groups measured after Balneotherapy were significantly increased compared to before Balneotherapy.
The systolic blood pressures of study groups measured before and after Balneotherapy were found as comparable.
The diastolic blood pressures of no hypertension and controlled hypertension groups measured before and after Balneotherapy were not statistically significant (P > 0.05); however, in the uncontrolled hypertension group, the diastolic blood pressure showed a decreasing trend after Balneotherapy (P < 0.05).



Balneotherapy can be safely used for patients with osteoarthritis, without resulting in any meaningful changes in systolic and diastolic blood pressures (normal and controlled hypertension) but a decrease in diastolic blood pressure with uncontrolled hypertension. This may be an advantage in osteoarthritis patients having hypertension as comorbid disease.


Original Article:
© North American Journal of Medical Sciences, November 2015, Volume 7, Issue 11, Page 517-523